Cargando…
Thrombotic Microangiopathy Presenting with Intestinal Involvement Following Long-term Interferon-β1b Treatment for Multiple Sclerosis
Thrombotic microangiopathies (TMAs) are systemic microvascular occlusive disorders. The present report describes a patient with relapsing-remitting multiple sclerosis who had been treated with interferon (IFN)-β1b therapy for eight years and developed TMA. The patient presented with headache, thromb...
Autores principales: | Omoto, Shusaku, Utsumi, Tomohiro, Matsuno, Hiromasa, Terasawa, Yuka, Iguchi, Yasuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874352/ https://www.ncbi.nlm.nih.gov/pubmed/29151517 http://dx.doi.org/10.2169/internalmedicine.9326-17 |
Ejemplares similares
-
Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
por: Malekzadeh, Masoud Mohammad, et al.
Publicado: (2020) -
Renal thrombotic microangiopathy induced by β-interferon
por: Li Cavoli, Gioacchino, et al.
Publicado: (2011) -
Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018) -
Thrombotic microangiopathy associated with use of interferon-beta
por: Olea, Teresa, et al.
Publicado: (2012) -
Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis
por: Mahe, Julien, et al.
Publicado: (2013)